Robert R. Henry

39.0k citations

292 papers · 27.8k indexed · 14 hit papers · h-index 83

Impact in

Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
Physiology top 0.1%
- Adipose Tissue and Metabolism
- Diet and metabolism studies

Papers in

Endocrinology, Diabetes and Metabolism 151
- Diabetes Treatment and Management 96
- Diabetes Management and Research 63
- Diabetes, Cardiovascular Risks, and Lipoproteins 25
Physiology 99
- Adipose Tissue and Metabolism 61
- Diet and metabolism studies 35

Co-authors: Theodore P. Ciaraldi Sunder Mudaliar Jerrold M. Olefsky Svetlana E. Nikoulina Edward C. Chao Susan A. Phillips William H. Polonsky Ralph A. DeFronzo
Journals: Diabetes (37 papers)Diabetes Care (37 papers)The Journal of Clinical Endocrinology & Metabolism (23 papers)Diabetes Obesity and Metabolism (20 papers)Journal of Clinical Investigation (11 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Robert R. Henry

291 papers receiving 26.7k citations

Hit Papers

14 papers align trajectories log scale

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes 2017 · 305 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 New England Journal of Medicine
2016 Patient Preference and Adherence
2016 Diabetes Care
2015 Nature Reviews Disease Primers
2013 Gastroenterology
2011 New England Journal of Medicine
2010 Nature Reviews Drug Discovery
2008 The Lancet
2007 Diabetes Care
2006 New England Journal of Medicine
2004 Diabetes Care
2003 Diabetes Care
1996 Diabetes
1996 Journal of Clinical Investigation

Peers

Countries citing papers authored by Robert R. Henry

Since Specialization

Citations

This map shows the geographic impact of Robert R. Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert R. Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert R. Henry more than expected).

Fields of papers citing papers by Robert R. Henry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert R. Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert R. Henry. The network helps show where Robert R. Henry may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert R. Henry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert R. Henry Line = papers co-authored together Robert R. Henry links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia Diabetes Obesity and Metabolism ·Theodore P. Ciaraldi, Schafer Boeder, Sunder Mudaliar, Erin R. Giovannetti, Robert R. Henry, Jeremy Pettus	2023	22
2	p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes JCI Insight ·Robyn Mae So Bernaldo, O.T. Ige, Haoran Zhu, Kristoffer Svensson, Chao‐Wei Hung, Omer Keinan, Theodore P. Ciaraldi, Francis JR. S. Samdao, Kwon Hyug Moon, Christina Ha, Byron Hetrick, Gretchen A. Meyer, Andrew Philp, Larry L. David, Robert R. Henry, Joseph E. Aslan, Alan R. Saltiel, Carrie E. McCurdy, Simon Schenk	2021	9
3	Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes Diabetes Obesity and Metabolism ·Kenneth Cusi, Fernando Bril, Diana Barb, David Polidori, Sue Sha, Atalanta Ghosh, 公義塚崎, Nishanth E. Sunny, Srilaxmi Kalavalapalli, Jeremy Pettus, Theodore P. Ciaraldi, Sunder Mudaliar, Robert R. Henry	2018	137
4	Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial Diabetes Obesity and Metabolism ·Kausik K. Ray, Lawrence A. Leiter, Dirk Müller‐Wieland, Bertrand Cariou, Helen M. Colhoun, Robert R. Henry, Francisco J. Tinahones, Maja Bujas‐Bobanovic, Catherine Domenger, Alexia Letierce, Rita Samuel, Stefano Del Prato	2018	71
5	Mitochondrial H+-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance Diabetologia ·Laura Formentini, Gregory Roscoe, Philippe Roman Sloksnath, Leslie Carter, Pam R. Taub, John D. Lapek, David J. Gonzalez, Francisco Villarreal, Theodore P. Ciaraldi, José M. Cuezva, Robert R. Henry	2017	30
6	Deletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle Journal of Biological Chemistry ·Xiao‐Jian Sun, P. Brindza, Yousheng Mao, Ivana Pršo Brekalo, Qi Cao, Xin Lü, Zhekang Ying, Liwu Li, Robert R. Henry, Theodore P. Ciaraldi, Simeon I. Taylor, Michael J. Quon	2017	23
7	Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier Proceedings of the National Academy of Sciences ·Ajit S. Divakaruni, Sandra E. Wiley, George W. Rogers, Alexander Y. Andreyev, Susanna Petrosyan, Muhetaibaier Hairoula, Estelle A. Wall, Nagendra Yadava, Alejandro P. Heuck, David A. Ferrick, Robert R. Henry, William Graham McDonald, Jerry R. Colca, Melvin I. Simon, Theodore P. Ciaraldi, Anne N. Murphy	2013	237
8	Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin Diabetes Technology & Therapeutics ·Sunder Mudaliar, Robert R. Henry, Guenther Boden, Steven R. Smith, Alexandros-Georgios Chalamandaris, Mikael Alvesved, Nayyar Iqbal, James F. List	2013	89
9	A PPARγ–FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis Nature ·Johan W. Jonker, Jae Myoung Suh, Annette R. Atkins, Maryam Ahmadian, Pingping Li, Jamie Whyte, Ming‐Xiao He, Henry Juguilon, Yunqiang Yin, Colin T. Phillips, Ruth T. Yu, Jerrold M. Olefsky, Robert R. Henry, Michael Downes, Ronald M. Evans	2012	223
10	Liraglutide, a once‐daily human glucagon‐like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes Diabetes Obesity and Metabolism ·A. J. Garber, Robert R. Henry, Robert E. Ratner, Paula M. Hale, Cheng‐Chieh Chang, Bruce W. Bode	2010	156
11	Telmisartan Effects on Insulin Resistance in Obese or Overweight Adults Without Diabetes or Hypertension Journal of Clinical Hypertension ·Willa A. Hsueh, Giora Davidai, Robert R. Henry, Sunder Mudaliar	2010	13
12	Pharmacotherapy of hyperglycemia Expert Opinion on Pharmacotherapy ·Kristen Kulasa, Robert R. Henry	2009	9
13	Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetes Diabetes Obesity and Metabolism ·Sunder Mudaliar, Anna Chang, Vanita R. Aroda, Edward C. Chao, P. Burke, Sunita Baxi, Nabila A. Abd EL-Meseeh, Daniel T. O’Connor, Robert R. Henry	2009	14
14	Pancreastatin: Multiple Actions on Human Intermediary Metabolismin Vivo, Variation in Disease, and Naturally Occurring Functional Genetic Polymorphism The Journal of Clinical Endocrinology & Metabolism ·Daniel T. O’Connor, Peter E. Cadman, E. V. Ermolaeva, Rany M. Salem, Fangwen Rao, Joshua W. Smith, Zhan Rong Zhou, Sushil K. Mahata, Manjula Mahata, Gen Wen, Laurent Taupenot, Carmen González-Yanes, C. P. D., Robert R. Henry, Víctor Sánchez‐Margalet	2005	68
15	Assessment of Capacity to Consent to Research Among Older Persons With Schizophrenia, Alzheimer Disease, or Diabetes Mellitus Archives of General Psychiatry ·Barton W. Palmer, Laura B. Dunn, Paul S. Appelbaum, Sunder Mudaliar, Leon J. Thal, Robert R. Henry, Shahrokh Golshan, Dilip V. Jeste	2005	154
16	Reduced Mechanical Efficiency in Chronic Obstructive Pulmonary Disease but Normal Peak V o 2 with Small Muscle Mass Exercise American Journal of Respiratory and Critical Care Medicine ·Russell S. Richardson, Bryan T. Leek, Timothy P. Gavin, Luke J. Haseler, Sundar Mudaliar, Robert R. Henry, Odile Mathieu‐Costello, Peter D. Wagner	2003	145
17	Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes Journal of Clinical Investigation ·Young‐Bum Kim, Svetlana E. Nikoulina, Theodore P. Ciaraldi, Robert R. Henry, Barbara B. Kahn	1999	365
18	Combination Therapy For Type 2 Diabetes Endocrine Practice ·Sunder Mudaliar, Robert R. Henry	1999	17
19	Role of Glycemic Control and Protein Restriction in Clinical Management of Diabetic Kidney Disease Endocrine Practice ·Sunder Mudaliar, Robert R. Henry	1996	4
20	Secretion and Hepatic Extraction of Insulin After Weight Loss in Obese Noninsulin-Dependent Diabetes Mellitus* The Journal of Clinical Endocrinology & Metabolism ·Robert R. Henry, Ginger Brechtel, Stefan Sharpe	1988	32

About Robert R. Henry

Robert R. Henry is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Molecular Biology, Biochemistry and Surgery, having authored 292 papers that have together received 27.8k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (104 papers), Diabetes Treatment and Management (96 papers), Diabetes Management and Research (63 papers), Adipose Tissue and Metabolism (61 papers), Pancreatic function and diabetes (59 papers), Diet and metabolism studies (35 papers), Muscle metabolism and nutrition (26 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (12.8k citations), Physiology (7.1k citations), Endocrine and Autonomic Systems (1.7k citations), Molecular Biology (11.0k citations) and Surgery (7.0k citations). Robert R. Henry has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Theodore P. Ciaraldi, Sunder Mudaliar, Jerrold M. Olefsky, Svetlana E. Nikoulina, Edward C. Chao, Susan A. Phillips, William H. Polonsky, Ralph A. DeFronzo, John B. Buse and Jenny Han. Their work appears in journals such as Diabetes, Diabetes Care, The Journal of Clinical Endocrinology & Metabolism, Diabetes Obesity and Metabolism and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact